Erratum
for
Scher et al., J Clin Oncol 22 (3) 537-556.
Journal of Clinical Oncology, Vol 22, No 15 (August 1), 2004: pp. 3205
© 2004 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2004.05.919
ERRATUM
The February 1, 2004, article by Scher et al entitled, "Eligibility and Outcomes Reporting Guidelines for Clinical Trials for Patients in the State of a Rising Prostate-Specific Antigen: Recommendations From the Prostate-Specific Antigen Working Group" (J Clin Oncol 22:537-556, 2004) contains an error.
A sentence in the first column and second full paragraph of page 552 mistakenly reads, "Factors that predict for a local as opposed to systemic recurrence are men with a low PSA (< 1 ng/mL), a long (> 1 year) time to failure, and a slow (> 1 year PSA-DT)." The corrected sentence should read, "Factors that predict for a local as opposed to systemic recurrence are men with a low PSA (< 1 ng/mL), a long (> 1 year) time to failure, and a slow (> 1 year) PSA doubling time (PSA-DT)."
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Facebook  Reddit  Technorati  Twitter What's this?
|
